Australia Life Science Tools Market Size, Share Analysis and Forecast Report (2025-2034)
Description
Australia Life Science Tools Market TrendsThe Australia life science tools market thrives through the integration of advanced technologies in genomics, proteomics, and diagnostics, which enhances research capabilities. The country fosters innovation with a strong network of universities and research institutions. Government funding and incentives drive sector growth, while high-quality medical devices improve diagnostics and patient care. The expanding healthcare sector increases demand for diagnostic, treatment, and prevention tools. In March 2024, Agilent Technologies launched innovative chromatography systems tailored for life science research in Australia, enhancing analytical capabilities for researchers, particularly in drug development.The Australia life science tools market development is also driven by advancements in precision medicine, enabling personalised diagnostics and treatment. Cutting-edge diagnostic tools improve early disease detection, leading to better patient outcomes. Australia’s well-established regulatory framework ensures the safety and efficacy of medical tools. A skilled biotechnology and healthcare workforce fosters innovation, and Australian-made tools gain international recognition, opening global export opportunities. In December 2023, PerkinElmer introduced a new automated liquid handling system for high-throughput laboratories in Australia, streamlining sample preparation, reducing human error, and enhancing research workflow efficiency.Australia Life Science Tools Market GrowthThe Australia life science tools market revenue is bolstered by the presence of global pharmaceutical companies and research labs, fostering collaboration and access to cutting-edge life science tools. The growing focus on health and wellness drives demand for diagnostic and therapeutic tools. Ongoing technological advancements enhance the efficiency and effectiveness of these tools, while increased venture capital investments fuel further innovation in biotechnology. These tools' robust data analysis capabilities support evidence-based patient care and research decisions. In April 2024, Illumina launched its latest next-generation sequencing platform in Australia, advancing genomic analysis for research and clinical applications, particularly in precision medicine.Advances in regenerative medicine and stem cell research are shaping the Australia life science tools market dynamics and trends. Sustainability initiatives are also gaining traction, with many tools being designed to reduce waste and energy consumption. Automation and high-throughput systems are increasing productivity in research labs and healthcare facilities. The ageing population in Australia further boosts demand for diagnostic and monitoring tools, while the country’s prominent role in clinical trials enhances the reliability of new therapies. In May 2024, Thermo Fisher Scientific introduced a new range of quantitative PCR (qPCR) products, including the QualTrak suite, which accelerates drug development in Australia.Australia Life Science Tools Market Insights
According to AusBiotech 2023, more than 800 biotechnology companies are operating in New South Wales, driving innovation in life science tools.
The Medical Research Future Fund (MRFF) has committed AUD 6.3 billion from 2022-23 to 2031-32 to support health and medical research initiatives.
In Western Australia, the life sciences sector employs over 10,000 people, making a substantial contribution to local employment, according to industry reports.Industry News October 2023 Sartorius introduced new bioreactor systems in Australia, specifically designed for biopharmaceutical manufacturing. These advanced tools improve process control and scalability, aiding the production of biologics and boosting overall efficiency in life science operations. July 2023 Roche launched cutting-edge diagnostic solutions in Australia, focusing on molecular testing. These tools are designed to improve the accuracy of disease detection and assist healthcare professionals by providing advanced technologies that lead to better patient outcomes across a range of medical fields.Australia Life Science Tools Market Drivers Advancements in Precision Medicine Precision medicine is a key trend in the Australia life science tools market, with the increasing ability to analyse genetic, environmental, and lifestyle factors enabling more personalised treatments. These advancements help clinicians customise therapies for individual patients, leading to improved treatment outcomes. Technologies such as next-generation sequencing (NGS), gene editing, and biomarker discovery are central to this shift. Australia's strong research ecosystem and government investment support the growth of precision medicine, making it a vital part of the country’s life sciences development. In June 2024, Abacus dx partnered with Roche to distribute advanced Molecular and Tissue Diagnostics solutions in Australia, enhancing research with tools like the LightCycler® and MagNA Pure Systems, which aid advancements in biotechnology and diagnostics. Integration of Artificial Intelligence and Machine Learning AI and ML are revolutionising the Australia life science tools market by enhancing data analysis, diagnostics, and treatment strategies. These technologies can process large volumes of biological and medical data quickly, helping to identify patterns and predict outcomes more accurately. AI is being applied in genomics, drug discovery, and precision medicine, with AI-powered drug development accelerating by identifying promising compounds and forecasting clinical trial success. The increased use of AI in life sciences improves decision-making, streamlines workflows, and significantly boosts research productivity across Australian institutions. In August 2024, Bio-Rad Laboratories launched a new digital PCR system in Australia, designed to improve nucleic acid quantification with enhanced precision and sensitivity for clinical diagnostics and research, supporting the rising demand for accurate genetic analysis.Opportunities in the Australia Life Science Tools Market Expansion of Regenerative Medicine and Stem Cell Research The growth of the Australia life science tools market is being driven by the rapid expansion of regenerative medicine, including stem cell research, supported by advancements in biotechnology and life science tools. Australian researchers are investigating the use of stem cells for tissue repair, organ regeneration, and treating degenerative diseases. The development of advanced bioreactors, gene editing tools, and other life science technologies is further promoting this field, enabling more efficient and scalable solutions. As the sector continues to progress, Australian companies are creating cutting-edge tools to support regenerative medicine research and clinical applications, positioning Australia as a leader in this promising area of healthcare innovation. In November 2023, QIAGEN launched advanced genomic analysis tools in Australia, designed to facilitate next-generation sequencing workflows, providing researchers with robust data analysis capabilities that support precision medicine and genomic research advancements.Market RestraintsThe Australia life science tools market faces several challenges that could hinder its growth. High costs associated with advanced technologies, such as next-generation sequencing (NGS) and diagnostic equipment, make them inaccessible to smaller institutions. Regulatory complexities and compliance with local and international standards can delay product development.Limited local manufacturing capacity increases dependence on imports, raising costs and vulnerability to supply chain disruptions. There is also a shortage of skilled professionals in specialised fields like genomics and bioinformatics, affecting productivity. While government support exists, funding remains competitive, making it harder for smaller companies to secure financial backing. Despite these obstacles, opportunities for innovation and investment remain.“Australia Life Science Tools Market Report and Forecast 2025-2034” offers a detailed analysis of the market based on the following segments:Market Breakup by Technology
Genomic Technology
Proteomics Technology
Cell Biology Technology
Others
Market Breakup by Product
Cell Culture Systems and 3D Cell Culture
Liquid Chromatography (LC)
Mass Spectrometry (MS)
Next-Generation Sequencing (NGS)
PCR and qPCR
Flow Cytometry
Microscopy and Electron Microscopy
Others
Market Breakup by End Use
Government and Academic
Biopharmaceutical Company
Healthcare
Industrial Applications
Others
Market Breakup by Region
New South Wales
Victoria
Queensland
Australian Capital Territory
Western Australia
Others
Australia Life Science Tools Market Share Market Analysis by Technology According to the Australia life science tools market analysis, genomic technology plays a key role, offering substantial benefits by enabling personalised medicine, improving disease prevention, and enhancing diagnostic accuracy. It allows healthcare providers to tailor treatments to individual genetic profiles, resulting in better patient outcomes and lower healthcare costs. This technology is essential in advancing precision medicine initiatives. In January 2024, Australian Genomics launched a national network aimed at integrating genomic testing into healthcare, enhancing accessibility and equity in genomic medicine across Australia and supporting improved health outcomes and personalised treatment options for patients.The demand of Australia life science tools market is also boosted by proteomics technology, which provides vital insights into protein functions and interactions, deepening our understanding of biological processes and disease mechanisms. In Australia, proteomics supports drug discovery, biomarker identification, and the development of targeted therapies, improving patient care and advancing research across various health sectors. In March 2024, Thermo Fisher Scientific introduced a new mass spectrometry platform in Australia for proteomics research. This platform enhances sensitivity and throughput for protein analysis, aiding researchers in drug development and disease biomarker discovery. Market Analysis by Product According to the Australia life science tools market report, the market is primarily driven by cell culture systems, especially 3D cell culture, which offer a more accurate representation of in vivo conditions. This technology improves the study of cellular interactions and drug responses, enhances drug discovery, reduces dependence on animal models, and boosts the predictive accuracy of preclinical studies, ultimately leading to more effective therapies. In January 2024, Corning launched a new range of advanced 3D cell culture products in Australia, designed to provide more physiologically relevant environments for studying cellular behaviour and drug responses, thus promoting innovation in biomedical research.The growth of the Australia life science tools market is further supported by liquid chromatography (LC), which is crucial for analysing complex biological samples, and providing high-resolution separation and quantification of biomolecules. In Australia, LC plays a vital role in drug development, quality control, and research applications by offering precise analytical capabilities that support regulatory compliance and enhance product safety. In November 2023, Waters Corporation introduced its new ultra-performance liquid chromatography (UPLC) technology in Australia. This advanced system delivers superior separation efficiency and speed, allowing researchers to achieve faster results while maintaining high analytical performance across various life science applications. Market Analysis by End Use The Australia life science tools market are strengthened as biopharmaceutical companies in the country play a key role in advancing healthcare through the development of innovative therapies and vaccines. These companies significantly contribute to the economy through job creation, research funding, and exports. The sector also benefits from strong government support, including tax incentives and funding programmes that encourage research and development. In November 2023, Medibank launched a new initiative to collaborate with Australian biopharmaceutical startups, aiming to accelerate the development of innovative health solutions and foster growth within the biopharmaceutical sector, ultimately enhancing patient care across the nation.The growth of the Australia life science tools market is further bolstered by the healthcare sector, which benefits from advanced life science tools that improve diagnostics, treatment, and patient care. These tools support research and development, leading to better health outcomes and more efficient healthcare delivery. The integration of technology in healthcare also drives innovation and economic growth. In January 2024, Telstra Health introduced an advanced telehealth platform to improve access to healthcare services across Australia. This platform enhances remote patient monitoring and consultation capabilities, enabling better healthcare delivery, particularly in rural areas.Australia Life Science Tools Market Regional Insights New South Wales Life Science Tools Market Overview The Australia life science tools industry analysis, New South Wales has a robust life science tools market, underpinned by substantial investments in research and development. This environment nurtures innovation improves healthcare services, and aids local biopharmaceutical companies in advancing therapies and diagnostics. In 2022-23, the state allocated AUD 1.2 billion to health and medical research, driving growth in life science tools and innovations. Queensland Life Science Tools Market Trends Queensland's life science tools market is witnessing growth, fuelled by increasing research and development activities and strong collaborations between universities and industry. This fosters innovation, enhances healthcare outcomes, and bolsters the local economy through job creation in the life sciences sector. Queensland dedicated AUD 800 million to health research funding in 2022-23 to advance life science tools and technologies. Western Australia Life Science Tools Market Dynamics Western Australia’s life science tools market thrives on its abundant natural resources and reputable research institutions. This dynamic environment drives progress in biotechnology and pharmaceuticals, boosting innovation and enhancing global competitiveness. In 2022-23, Western Australia invested AUD 500 million in health and medical research initiatives, promoting the development of life science tools within the state.Competitive LandscapeThe Australia life science tools market key players develop and manufacture a wide range of products, including prescription medicines, diagnostics, and medical devices. Their key therapeutic areas include oncology, immunology, neuroscience, and infectious diseases. Through their pharmaceutical and diagnostic divisions, these companies continue to drive breakthroughs in drug development and diagnostic technologies, making significant contributions to the global healthcare sector.Key Industry Players Agilent Technologies Inc.: Headquartered in Santa Clara, California, USA, Agilent Technologies was established in 1999. The company is a leading provider of analytical instruments, laboratory equipment, and life sciences solutions. It offers a wide range of tools and services for research, diagnostics, and healthcare, focusing on chemical analysis, genomics, and diagnostics. Becton Dickinson & Co.: It is headquartered in Franklin Lakes, New Jersey, USA, and was founded in 1897. It is a global leader in medical devices, laboratory equipment, and diagnostic systems. BD focuses on advancing healthcare by providing innovative solutions for medication management, infection prevention, and diagnostic testing across various medical fields. Roche Holding AG: Based in Basel, Switzerland, was founded in 1896. It is one of the world's largest pharmaceutical and diagnostics companies, known for its work in oncology, immunology, and diagnostics. Roche provides high-quality life science tools and cutting-edge technology for research, diagnostics, and patient care. Bio-Rad Laboratories, Inc.: Established in 1952 and is headquartered in Hercules, California, USA. The company develops and manufactures life science research products, including reagents, instruments, and systems for biotechnology, pharmaceuticals, and academia. Bio-Rad is a key player in the development of tools for genomics, proteomics, and diagnostics.Other key players in the Australia life science tools market report are Illumina, Inc., ThermoFisher Scientific Australia Pty Ltd., QIAGEN Pty Ltd., Merck Healthcare Pty Ltd., Bruker Pty Ltd., and Oxford Instruments Plc, among Others
.Recent Developments November 2023 SeqGen launched a range of genomic testing services specifically designed for Australian healthcare providers. These services are intended to enhance diagnostic capabilities and support personalised treatment plans, helping to drive the increasing use of genomics in clinical practice. July 2023 Promega introduced a series of 3D cell culture kits for cancer research in Australia. These kits simplify the process of culturing organoids, allowing researchers to more accurately model tumour microenvironments and assess therapeutic responses more efficiently.
According to AusBiotech 2023, more than 800 biotechnology companies are operating in New South Wales, driving innovation in life science tools.
The Medical Research Future Fund (MRFF) has committed AUD 6.3 billion from 2022-23 to 2031-32 to support health and medical research initiatives.
In Western Australia, the life sciences sector employs over 10,000 people, making a substantial contribution to local employment, according to industry reports.Industry News October 2023 Sartorius introduced new bioreactor systems in Australia, specifically designed for biopharmaceutical manufacturing. These advanced tools improve process control and scalability, aiding the production of biologics and boosting overall efficiency in life science operations. July 2023 Roche launched cutting-edge diagnostic solutions in Australia, focusing on molecular testing. These tools are designed to improve the accuracy of disease detection and assist healthcare professionals by providing advanced technologies that lead to better patient outcomes across a range of medical fields.Australia Life Science Tools Market Drivers Advancements in Precision Medicine Precision medicine is a key trend in the Australia life science tools market, with the increasing ability to analyse genetic, environmental, and lifestyle factors enabling more personalised treatments. These advancements help clinicians customise therapies for individual patients, leading to improved treatment outcomes. Technologies such as next-generation sequencing (NGS), gene editing, and biomarker discovery are central to this shift. Australia's strong research ecosystem and government investment support the growth of precision medicine, making it a vital part of the country’s life sciences development. In June 2024, Abacus dx partnered with Roche to distribute advanced Molecular and Tissue Diagnostics solutions in Australia, enhancing research with tools like the LightCycler® and MagNA Pure Systems, which aid advancements in biotechnology and diagnostics. Integration of Artificial Intelligence and Machine Learning AI and ML are revolutionising the Australia life science tools market by enhancing data analysis, diagnostics, and treatment strategies. These technologies can process large volumes of biological and medical data quickly, helping to identify patterns and predict outcomes more accurately. AI is being applied in genomics, drug discovery, and precision medicine, with AI-powered drug development accelerating by identifying promising compounds and forecasting clinical trial success. The increased use of AI in life sciences improves decision-making, streamlines workflows, and significantly boosts research productivity across Australian institutions. In August 2024, Bio-Rad Laboratories launched a new digital PCR system in Australia, designed to improve nucleic acid quantification with enhanced precision and sensitivity for clinical diagnostics and research, supporting the rising demand for accurate genetic analysis.Opportunities in the Australia Life Science Tools Market Expansion of Regenerative Medicine and Stem Cell Research The growth of the Australia life science tools market is being driven by the rapid expansion of regenerative medicine, including stem cell research, supported by advancements in biotechnology and life science tools. Australian researchers are investigating the use of stem cells for tissue repair, organ regeneration, and treating degenerative diseases. The development of advanced bioreactors, gene editing tools, and other life science technologies is further promoting this field, enabling more efficient and scalable solutions. As the sector continues to progress, Australian companies are creating cutting-edge tools to support regenerative medicine research and clinical applications, positioning Australia as a leader in this promising area of healthcare innovation. In November 2023, QIAGEN launched advanced genomic analysis tools in Australia, designed to facilitate next-generation sequencing workflows, providing researchers with robust data analysis capabilities that support precision medicine and genomic research advancements.Market RestraintsThe Australia life science tools market faces several challenges that could hinder its growth. High costs associated with advanced technologies, such as next-generation sequencing (NGS) and diagnostic equipment, make them inaccessible to smaller institutions. Regulatory complexities and compliance with local and international standards can delay product development.Limited local manufacturing capacity increases dependence on imports, raising costs and vulnerability to supply chain disruptions. There is also a shortage of skilled professionals in specialised fields like genomics and bioinformatics, affecting productivity. While government support exists, funding remains competitive, making it harder for smaller companies to secure financial backing. Despite these obstacles, opportunities for innovation and investment remain.“Australia Life Science Tools Market Report and Forecast 2025-2034” offers a detailed analysis of the market based on the following segments:Market Breakup by Technology
Genomic Technology
Proteomics Technology
Cell Biology Technology
Others
Market Breakup by Product
Cell Culture Systems and 3D Cell Culture
Liquid Chromatography (LC)
Mass Spectrometry (MS)
Next-Generation Sequencing (NGS)
PCR and qPCR
Flow Cytometry
Microscopy and Electron Microscopy
Others
Market Breakup by End Use
Government and Academic
Biopharmaceutical Company
Healthcare
Industrial Applications
Others
Market Breakup by Region
New South Wales
Victoria
Queensland
Australian Capital Territory
Western Australia
Others
Australia Life Science Tools Market Share Market Analysis by Technology According to the Australia life science tools market analysis, genomic technology plays a key role, offering substantial benefits by enabling personalised medicine, improving disease prevention, and enhancing diagnostic accuracy. It allows healthcare providers to tailor treatments to individual genetic profiles, resulting in better patient outcomes and lower healthcare costs. This technology is essential in advancing precision medicine initiatives. In January 2024, Australian Genomics launched a national network aimed at integrating genomic testing into healthcare, enhancing accessibility and equity in genomic medicine across Australia and supporting improved health outcomes and personalised treatment options for patients.The demand of Australia life science tools market is also boosted by proteomics technology, which provides vital insights into protein functions and interactions, deepening our understanding of biological processes and disease mechanisms. In Australia, proteomics supports drug discovery, biomarker identification, and the development of targeted therapies, improving patient care and advancing research across various health sectors. In March 2024, Thermo Fisher Scientific introduced a new mass spectrometry platform in Australia for proteomics research. This platform enhances sensitivity and throughput for protein analysis, aiding researchers in drug development and disease biomarker discovery. Market Analysis by Product According to the Australia life science tools market report, the market is primarily driven by cell culture systems, especially 3D cell culture, which offer a more accurate representation of in vivo conditions. This technology improves the study of cellular interactions and drug responses, enhances drug discovery, reduces dependence on animal models, and boosts the predictive accuracy of preclinical studies, ultimately leading to more effective therapies. In January 2024, Corning launched a new range of advanced 3D cell culture products in Australia, designed to provide more physiologically relevant environments for studying cellular behaviour and drug responses, thus promoting innovation in biomedical research.The growth of the Australia life science tools market is further supported by liquid chromatography (LC), which is crucial for analysing complex biological samples, and providing high-resolution separation and quantification of biomolecules. In Australia, LC plays a vital role in drug development, quality control, and research applications by offering precise analytical capabilities that support regulatory compliance and enhance product safety. In November 2023, Waters Corporation introduced its new ultra-performance liquid chromatography (UPLC) technology in Australia. This advanced system delivers superior separation efficiency and speed, allowing researchers to achieve faster results while maintaining high analytical performance across various life science applications. Market Analysis by End Use The Australia life science tools market are strengthened as biopharmaceutical companies in the country play a key role in advancing healthcare through the development of innovative therapies and vaccines. These companies significantly contribute to the economy through job creation, research funding, and exports. The sector also benefits from strong government support, including tax incentives and funding programmes that encourage research and development. In November 2023, Medibank launched a new initiative to collaborate with Australian biopharmaceutical startups, aiming to accelerate the development of innovative health solutions and foster growth within the biopharmaceutical sector, ultimately enhancing patient care across the nation.The growth of the Australia life science tools market is further bolstered by the healthcare sector, which benefits from advanced life science tools that improve diagnostics, treatment, and patient care. These tools support research and development, leading to better health outcomes and more efficient healthcare delivery. The integration of technology in healthcare also drives innovation and economic growth. In January 2024, Telstra Health introduced an advanced telehealth platform to improve access to healthcare services across Australia. This platform enhances remote patient monitoring and consultation capabilities, enabling better healthcare delivery, particularly in rural areas.Australia Life Science Tools Market Regional Insights New South Wales Life Science Tools Market Overview The Australia life science tools industry analysis, New South Wales has a robust life science tools market, underpinned by substantial investments in research and development. This environment nurtures innovation improves healthcare services, and aids local biopharmaceutical companies in advancing therapies and diagnostics. In 2022-23, the state allocated AUD 1.2 billion to health and medical research, driving growth in life science tools and innovations. Queensland Life Science Tools Market Trends Queensland's life science tools market is witnessing growth, fuelled by increasing research and development activities and strong collaborations between universities and industry. This fosters innovation, enhances healthcare outcomes, and bolsters the local economy through job creation in the life sciences sector. Queensland dedicated AUD 800 million to health research funding in 2022-23 to advance life science tools and technologies. Western Australia Life Science Tools Market Dynamics Western Australia’s life science tools market thrives on its abundant natural resources and reputable research institutions. This dynamic environment drives progress in biotechnology and pharmaceuticals, boosting innovation and enhancing global competitiveness. In 2022-23, Western Australia invested AUD 500 million in health and medical research initiatives, promoting the development of life science tools within the state.Competitive LandscapeThe Australia life science tools market key players develop and manufacture a wide range of products, including prescription medicines, diagnostics, and medical devices. Their key therapeutic areas include oncology, immunology, neuroscience, and infectious diseases. Through their pharmaceutical and diagnostic divisions, these companies continue to drive breakthroughs in drug development and diagnostic technologies, making significant contributions to the global healthcare sector.Key Industry Players Agilent Technologies Inc.: Headquartered in Santa Clara, California, USA, Agilent Technologies was established in 1999. The company is a leading provider of analytical instruments, laboratory equipment, and life sciences solutions. It offers a wide range of tools and services for research, diagnostics, and healthcare, focusing on chemical analysis, genomics, and diagnostics. Becton Dickinson & Co.: It is headquartered in Franklin Lakes, New Jersey, USA, and was founded in 1897. It is a global leader in medical devices, laboratory equipment, and diagnostic systems. BD focuses on advancing healthcare by providing innovative solutions for medication management, infection prevention, and diagnostic testing across various medical fields. Roche Holding AG: Based in Basel, Switzerland, was founded in 1896. It is one of the world's largest pharmaceutical and diagnostics companies, known for its work in oncology, immunology, and diagnostics. Roche provides high-quality life science tools and cutting-edge technology for research, diagnostics, and patient care. Bio-Rad Laboratories, Inc.: Established in 1952 and is headquartered in Hercules, California, USA. The company develops and manufactures life science research products, including reagents, instruments, and systems for biotechnology, pharmaceuticals, and academia. Bio-Rad is a key player in the development of tools for genomics, proteomics, and diagnostics.Other key players in the Australia life science tools market report are Illumina, Inc., ThermoFisher Scientific Australia Pty Ltd., QIAGEN Pty Ltd., Merck Healthcare Pty Ltd., Bruker Pty Ltd., and Oxford Instruments Plc, among Others
.Recent Developments November 2023 SeqGen launched a range of genomic testing services specifically designed for Australian healthcare providers. These services are intended to enhance diagnostic capabilities and support personalised treatment plans, helping to drive the increasing use of genomics in clinical practice. July 2023 Promega introduced a series of 3D cell culture kits for cancer research in Australia. These kits simplify the process of culturing organoids, allowing researchers to more accurately model tumour microenvironments and assess therapeutic responses more efficiently.
Table of Contents
101 Pages
- 1 Preface
- 2 Report Coverage – Key Segmentation and Scope
- 3 Report Description
- 3.1 Market Definition and Outlook
- 3.2 Properties and Applications
- 3.3 Market Analysis
- 3.4 Key Players
- 4 Key Assumptions
- 5 Executive Summary
- 5.1 Overview
- 5.2 Key Drivers
- 5.3 Key Developments
- 5.4 Competitive Structure
- 5.5 Key Industrial Trends
- 6 Market Snapshot
- 7 Opportunities and Challenges in the Market
- 8 Asia Pacific Life Science Tools Market Overview
- 8.1 Key Industry Highlights
- 8.2 Asia Pacific Life Science Tools Historical Market (2018-2024)
- 8.3 Asia Pacific Life Science Tools Market Forecast (2025-2034)
- 9 Australia Life Science Tools Market Overview
- 9.1 Key Industry Highlights
- 9.2 Australia Life Science Tools Historical Market (2018-2024)
- 9.3 Australia Life Science Tools Market Forecast (2025-2034)
- 10 Australia Life Science Tools Market by Technology
- 10.1 Genomic Technology
- 10.1.1 Historical Trend (2018-2024)
- 10.1.2 Forecast Trend (2025-2034)
- 10.2 Proteomics Technology
- 10.2.1 Historical Trend (2018-2024)
- 10.2.2 Forecast Trend (2025-2034)
- 10.3 Cell Biology Technology
- 10.3.1 Historical Trend (2018-2024)
- 10.3.2 Forecast Trend (2025-2034)
- 10.4 Others
- 11 Australia Life Science Tools Market by Product
- 11.1 Cell Culture Systems and 3D Cell Culture
- 11.1.1 Historical Trend (2018-2024)
- 11.1.2 Forecast Trend (2025-2034)
- 11.2 Liquid Chromatography (LC)
- 11.2.1 Historical Trend (2018-2024)
- 11.2.2 Forecast Trend (2025-2034)
- 11.3 Mass Spectrometry (MS)
- 11.3.1 Historical Trend (2018-2024)
- 11.3.2 Forecast Trend (2025-2034)
- 11.4 Next-Generation Sequencing (NGS)
- 11.4.1 Historical Trend (2018-2024)
- 11.4.2 Forecast Trend (2025-2034)
- 11.5 PCR and qPCR
- 11.5.1 Historical Trend (2018-2024)
- 11.5.2 Forecast Trend (2025-2034)
- 11.6 Flow Cytometry
- 11.6.1 Historical Trend (2018-2024)
- 11.6.2 Forecast Trend (2025-2034)
- 11.7 Microscopy and Electron Microscopy
- 11.7.1 Historical Trend (2018-2024)
- 11.7.2 Forecast Trend (2025-2034)
- 11.8 Others
- 12 Australia Life Science Tools Market by End Use
- 12.1 Government and Academic
- 12.1.1 Historical Trend (2018-2024)
- 12.1.2 Forecast Trend (2025-2034)
- 12.2 Biopharmaceutical Company
- 12.2.1 Historical Trend (2018-2024)
- 12.2.2 Forecast Trend (2025-2034)
- 12.3 Healthcare
- 12.3.1 Historical Trend (2018-2024)
- 12.3.2 Forecast Trend (2025-2034)
- 12.4 Industrial Applications
- 12.4.1 Historical Trend (2018-2024)
- 12.4.2 Forecast Trend (2025-2034)
- 12.5 Others
- 13 Australia Life Science Tools Market by Region
- 13.1 New South Wales
- 13.1.1 Historical Trend (2018-2024)
- 13.1.2 Forecast Trend (2025-2034)
- 13.2 Victoria
- 13.2.1 Historical Trend (2018-2024)
- 13.2.2 Forecast Trend (2025-2034)
- 13.3 Queensland
- 13.3.1 Historical Trend (2018-2024)
- 13.3.2 Forecast Trend (2025-2034)
- 13.4 Australian Capital Territory
- 13.4.1 Historical Trend (2018-2024)
- 13.4.2 Forecast Trend (2025-2034)
- 13.5 Western Australia
- 13.5.1 Historical Trend (2018-2024)
- 13.5.2 Forecast Trend (2025-2034)
- 13.6 Others
- 14 Market Dynamics
- 14.1 SWOT Analysis
- 14.1.1 Strengths
- 14.1.2 Weaknesses
- 14.1.3 Opportunities
- 14.1.4 Threats
- 14.2 Porter’s Five Forces Analysis
- 14.2.1 Supplier’s Power
- 14.2.2 Buyer’s Power
- 14.2.3 Threat of New Entrants
- 14.2.4 Degree of Rivalry
- 14.2.5 Threat of Substitutes
- 14.3 Key Indicators of Demand
- 14.4 Key Indicators of Price
- 15 Value Chain Analysis
- 16 Competitive Landscape
- 16.1 Market Structure
- 16.2 Company Profile
- 16.2.1 Agilent Technologies Inc.
- 16.2.1.1 Company Overview
- 16.2.1.2 Product Portfolio
- 16.2.1.3 Demographic Reach and Achievements
- 16.2.1.4 Certifications
- 16.2.2 Becton Dickinson & Co.
- 16.2.2.1 Company Overview
- 16.2.2.2 Product Portfolio
- 16.2.2.3 Demographic Reach and Achievements
- 16.2.2.4 Certifications
- 16.2.3 Roche Holding AG
- 16.2.3.1 Company Overview
- 16.2.3.2 Product Portfolio
- 16.2.3.3 Demographic Reach and Achievements
- 16.2.3.4 Certifications
- 16.2.4 Bio-Rad Laboratories, Inc.
- 16.2.4.1 Company Overview
- 16.2.4.2 Product Portfolio
- 16.2.4.3 Demographic Reach and Achievements
- 16.2.4.4 Certifications
- 16.2.5 Illumina, Inc.
- 16.2.5.1 Company Overview
- 16.2.5.2 Product Portfolio
- 16.2.5.3 Demographic Reach and Achievements
- 16.2.5.4 Certifications
- 16.2.6 ThermoFisher Scientific Australia Pty Ltd.
- 16.2.6.1 Company Overview
- 16.2.6.2 Product Portfolio
- 16.2.6.3 Demographic Reach and Achievements
- 16.2.6.4 Certifications
- 16.2.7 QIAGEN Pty Ltd.
- 16.2.7.1 Company Overview
- 16.2.7.2 Product Portfolio
- 16.2.7.3 Demographic Reach and Achievements
- 16.2.7.4 Certifications
- 16.2.8 Merck Healthcare Pty Ltd.
- 16.2.8.1 Company Overview
- 16.2.8.2 Product Portfolio
- 16.2.8.3 Demographic Reach and Achievements
- 16.2.8.4 Certifications
- 16.2.9 Bruker Pty Ltd.
- 16.2.9.1 Company Overview
- 16.2.9.2 Product Portfolio
- 16.2.9.3 Demographic Reach and Achievements
- 16.2.9.4 Certifications
- 16.2.10 Oxford Instruments Plc
- 16.2.10.1 Company Overview
- 16.2.10.2 Product Portfolio
- 16.2.10.3 Demographic Reach and Achievements
- 16.2.10.4 Certifications
- 16.2.11 Others
- 17 Key Trends and Developments in the Market
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.